Galera Therapeutics Inc. With a focus on developing innovative therapies, Galera aims to reduce the toxicities associated with radiotherapy and enhance the anti-cancer efficacy of radiation treatment. Through their groundbreaking scientific approach, Galera leverages superoxide dismutase mimetics to achieve these goals.

The company's mission is centered around prioritizing patients receiving radiotherapy, striving to improve their treatment outcomes. Galera Therapeutics firmly believes that their unique science can make a significant impact on cancer patients' lives by minimizing the side effects of radiotherapy and maximizing its effectiveness against cancer cells. With a commitment to patients and a dedication to advancing the field of radiotherapy, Galera Therapeutics is at the forefront of transforming cancer treatment.

Their pioneering research and development efforts offer hope for a future where radiotherapy becomes more tolerable and successful for patients battling cancer. Visit their website to learn more about their transformative work and the latest advancements in the field